Moelis & Company (NYSE:MC - Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 4,610,000 shares, an increase of 20.1% from the February 28th total of 3,840,000 shares. Approximately 6.6% of the shares of the company are short sold. Based on an average daily volume of 894,000 shares, the days-to-cover ratio is currently 5.2 days.
Moelis & Company Price Performance
Shares of NYSE:MC traded down $0.67 during midday trading on Monday, reaching $49.89. The company's stock had a trading volume of 596,643 shares, compared to its average volume of 707,136. The business's fifty day simple moving average is $67.95 and its 200-day simple moving average is $71.07. The company has a market capitalization of $3.74 billion, a P/E ratio of 28.25 and a beta of 1.53. Moelis & Company has a fifty-two week low of $46.24 and a fifty-two week high of $82.89.
Moelis & Company (NYSE:MC - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The asset manager reported $1.18 earnings per share for the quarter, beating analysts' consensus estimates of $0.39 by $0.79. Moelis & Company had a net margin of 11.39% and a return on equity of 38.49%. On average, analysts forecast that Moelis & Company will post 2.97 earnings per share for the current fiscal year.
Moelis & Company Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, March 27th. Stockholders of record on Tuesday, February 18th were paid a dividend of $0.65 per share. This represents a $2.60 dividend on an annualized basis and a dividend yield of 5.21%. The ex-dividend date of this dividend was Tuesday, February 18th. This is a boost from Moelis & Company's previous quarterly dividend of $0.60. Moelis & Company's dividend payout ratio (DPR) is currently 147.73%.
Wall Street Analyst Weigh In
A number of brokerages have commented on MC. Morgan Stanley reiterated an "underweight" rating and issued a $70.00 price objective (down previously from $100.00) on shares of Moelis & Company in a report on Thursday, March 13th. Keefe, Bruyette & Woods reaffirmed an "outperform" rating and set a $92.00 target price (up previously from $86.00) on shares of Moelis & Company in a research note on Thursday, February 6th. StockNews.com downgraded shares of Moelis & Company from a "buy" rating to a "hold" rating in a research report on Thursday, March 13th. The Goldman Sachs Group decreased their target price on Moelis & Company from $86.00 to $75.00 and set a "neutral" rating for the company in a research note on Friday, March 14th. Finally, Wells Fargo & Company upped their price target on shares of Moelis & Company from $77.00 to $83.00 and gave the company an "equal weight" rating in a research report on Thursday, February 6th. Two analysts have rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, Moelis & Company presently has a consensus rating of "Hold" and a consensus price target of $71.83.
Read Our Latest Research Report on MC
Insider Buying and Selling
In other news, insider Christopher Callesano sold 1,282 shares of the company's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $74.00, for a total value of $94,868.00. Following the sale, the insider now directly owns 1,227 shares in the company, valued at $90,798. This represents a 51.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kenneth Shropshire sold 2,551 shares of the firm's stock in a transaction on Friday, February 21st. The stock was sold at an average price of $72.30, for a total value of $184,437.30. Following the sale, the director now owns 6,940 shares in the company, valued at $501,762. This trade represents a 26.88 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 22,721 shares of company stock valued at $1,677,017 over the last three months. 6.40% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Moelis & Company
A number of institutional investors have recently modified their holdings of the business. Edgestream Partners L.P. acquired a new position in Moelis & Company during the 4th quarter worth approximately $2,784,000. Charles Schwab Investment Management Inc. lifted its stake in shares of Moelis & Company by 1.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 935,552 shares of the asset manager's stock valued at $69,119,000 after purchasing an additional 12,632 shares during the period. Hodges Capital Management Inc. bought a new position in shares of Moelis & Company during the 4th quarter worth approximately $9,149,000. Cerity Partners LLC grew its holdings in Moelis & Company by 129.8% in the third quarter. Cerity Partners LLC now owns 13,845 shares of the asset manager's stock worth $949,000 after purchasing an additional 7,819 shares during the period. Finally, Entropy Technologies LP acquired a new stake in shares of Moelis & Company in the 4th quarter valued at about $412,000. Institutional investors own 91.53% of the company's stock.
About Moelis & Company
(
Get Free Report)
Moelis & Co operates as a holding company. It engages in the provision of financial advisory, capital raising and asset management services to a client base including corporations, governments, sovereign wealth funds and financial sponsors. The firm focuses on clients including large public multinational corporations, middle market private companies, financial sponsors, entrepreneurs and governments.
Further Reading
Before you consider Moelis & Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moelis & Company wasn't on the list.
While Moelis & Company currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.